BE2015C005I2 - - Google Patents

Download PDF

Info

Publication number
BE2015C005I2
BE2015C005I2 BE2015C005C BE2015C005C BE2015C005I2 BE 2015C005 I2 BE2015C005 I2 BE 2015C005I2 BE 2015C005 C BE2015C005 C BE 2015C005C BE 2015C005 C BE2015C005 C BE 2015C005C BE 2015C005 I2 BE2015C005 I2 BE 2015C005I2
Authority
BE
Belgium
Application number
BE2015C005C
Other languages
French (fr)
Original Assignee
Univ Pittsburgh Commonwealth Sys Higher Education
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/388,173 external-priority patent/US7270800B2/en
Priority claimed from US10/645,847 external-priority patent/US20050043523A1/en
Application filed by Univ Pittsburgh Commonwealth Sys Higher Education filed Critical Univ Pittsburgh Commonwealth Sys Higher Education
Publication of BE2015C005I2 publication Critical patent/BE2015C005I2/fr

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896Neurological disorders, e.g. Alzheimer's disease
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62Benzothiazoles
    • C07D277/64Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
    • C07D277/66Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2 with aromatic rings or ring systems directly attached in position 2
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/60Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances involving radioactive labelled substances

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Neurosurgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
BE2015C005C 2003-03-14 2015-01-27 BE2015C005I2 (US07179617-20070220-C00025.png)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/388,173 US7270800B2 (en) 2000-08-24 2003-03-14 Thioflavin derivatives for use in antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition
US10/645,847 US20050043523A1 (en) 2003-08-22 2003-08-22 Benzothiazole derivative compounds, compositions and uses

Publications (1)

Publication Number Publication Date
BE2015C005I2 true BE2015C005I2 (US07179617-20070220-C00025.png) 2023-03-07

Family

ID=35057877

Family Applications (1)

Application Number Title Priority Date Filing Date
BE2015C005C BE2015C005I2 (US07179617-20070220-C00025.png) 2003-03-14 2015-01-27

Country Status (16)

Country Link
EP (1) EP1611115B1 (US07179617-20070220-C00025.png)
JP (1) JP4875487B2 (US07179617-20070220-C00025.png)
CN (2) CN1784392A (US07179617-20070220-C00025.png)
AU (2) AU2004221897B2 (US07179617-20070220-C00025.png)
BE (1) BE2015C005I2 (US07179617-20070220-C00025.png)
BR (1) BRPI0408274B8 (US07179617-20070220-C00025.png)
CY (2) CY1113334T1 (US07179617-20070220-C00025.png)
DK (1) DK1611115T3 (US07179617-20070220-C00025.png)
ES (1) ES2393921T3 (US07179617-20070220-C00025.png)
HK (1) HK1086270A1 (US07179617-20070220-C00025.png)
HU (1) HUS1500006I1 (US07179617-20070220-C00025.png)
NO (3) NO330861B1 (US07179617-20070220-C00025.png)
PL (1) PL1611115T3 (US07179617-20070220-C00025.png)
PT (1) PT1611115E (US07179617-20070220-C00025.png)
RU (1) RU2440995C2 (US07179617-20070220-C00025.png)
SI (1) SI1611115T1 (US07179617-20070220-C00025.png)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7270800B2 (en) 2000-08-24 2007-09-18 University Of Pittsburgh Thioflavin derivatives for use in antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition
AU8670201A (en) 2000-08-24 2002-03-04 Univ Pittsburgh Thioflavin derivatives for use in antemortem diagnosis of alzheimer's disease and in vivo imaging and prevention of amyloid deposition
WO2005112913A1 (en) * 2004-05-20 2005-12-01 The Scripps Research Institute Transthyretin stabilization
GB0516564D0 (en) * 2005-08-12 2005-09-21 Ge Healthcare Ltd Fluorination process
MX2009007880A (es) * 2007-01-30 2009-08-18 Ge Healthcare Ltd Herramientas para ayudar en el diagnostico de enfermedades neurodegenerativas.
CN101293878B (zh) * 2007-04-25 2010-12-15 中国科学院上海应用物理研究所 苯并噻唑苯胺类化合物及其制备方法和应用
JP2011529086A (ja) * 2008-07-24 2011-12-01 シーメンス メディカル ソリューションズ ユーエスエー インコーポレイテッド Ad病変を同定するために有用な造影剤
PT2338059E (pt) * 2008-09-23 2015-08-03 Wista Lab Ltd Ligandos para moléculas de tau agregada
EP3049411B1 (en) * 2013-09-26 2017-04-26 F. Hoffmann-La Roche AG Imidazo[1,2-a]pyridin-7-amines as imaging tools
JP6260967B2 (ja) * 2013-11-06 2018-01-17 国立大学法人京都大学 放射性ヨウ素標識化合物、及び、これを含む放射性医薬
CN103613589B (zh) * 2013-11-29 2016-03-30 江苏华益科技有限公司 一种用于神经退行性疾病领域的新型pet显像剂前体及标准品的合成方法
MX2017002705A (es) * 2014-08-29 2017-12-20 Chdi Foundation Inc Sondas para la proyección de imagen de la proteína huntingtina.
CN109400615B (zh) * 2017-08-18 2021-07-16 上海交通大学医学院附属新华医院 一种靶向β-淀粉样蛋白的香豆素类化合物及其制备与应用
GR1009516B (el) * 2018-03-22 2019-05-02 Εκεφε Δημοκριτος Τρικαρβονυλο-συμπλοκα μεταλλων μεταπτωσεως με βενζο-ετεροκυκλικο παραγωγο του κυκλοπενταδιενυλικου ανιοντος με υψηλη διαπερατοτητα του αιματοεγκεφαλικου φραγμου για εφαρμογες στη διαγνωση και θεραπεια νοσων του κνς

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ335157A (en) * 1996-11-22 2001-01-26 Elan Pharm Inc N-(aryl/heteroaryl) amino acid derivatives and methods for inhibiting beta-amyloid peptide release or its synthesis
GB9919673D0 (en) * 1999-08-20 1999-10-20 Cancer Res Campaign Tech 2-Arlybenzazole compounds
AU8670201A (en) * 2000-08-24 2002-03-04 Univ Pittsburgh Thioflavin derivatives for use in antemortem diagnosis of alzheimer's disease and in vivo imaging and prevention of amyloid deposition
EP1345914A1 (en) * 2000-12-22 2003-09-24 AstraZeneca AB Therapeutic compounds
CN100422180C (zh) * 2001-04-23 2008-10-01 宾夕法尼亚州大学理事会 淀粉样斑块聚集抑制剂和诊断成像剂
GB0229686D0 (en) * 2002-12-20 2003-01-29 Amersham Plc Solid-phase fluorination of benzothiazoles

Also Published As

Publication number Publication date
AU2004221897B2 (en) 2010-11-18
AU2004221897A1 (en) 2004-09-30
NO2015005I2 (no) 2015-02-18
RU2005131872A (ru) 2006-02-27
DK1611115T3 (da) 2012-11-26
CY2015007I1 (el) 2015-12-09
EP1611115B1 (en) 2012-08-22
NO20054674L (no) 2005-12-13
NO20110980L (no) 2005-12-13
JP4875487B2 (ja) 2012-02-15
ES2393921T3 (es) 2013-01-02
BRPI0408274B1 (pt) 2019-02-26
SI1611115T1 (sl) 2012-12-31
AU2011200667A1 (en) 2011-03-10
AU2004221897A9 (en) 2009-08-20
NO2015005I1 (no) 2015-03-02
RU2440995C2 (ru) 2012-01-27
HUS1500006I1 (hu) 2015-02-18
BRPI0408274A (pt) 2006-03-21
PL1611115T3 (pl) 2013-01-31
AU2004221897A2 (en) 2004-09-30
CN102532055A (zh) 2012-07-04
EP1611115A1 (en) 2006-01-04
CN1784392A (zh) 2006-06-07
PT1611115E (pt) 2012-12-07
HK1086270A1 (en) 2006-09-15
NO330861B1 (no) 2011-08-01
CY1113334T1 (el) 2015-12-09
AU2011200667B2 (en) 2011-12-22
JP2006522104A (ja) 2006-09-28
BRPI0408274B8 (pt) 2021-05-25
NO20054674D0 (no) 2005-10-11
CN102532055B (zh) 2016-05-11

Similar Documents

Publication Publication Date Title
BE2015C007I2 (US07179617-20070220-C00025.png)
BE2014C055I2 (US07179617-20070220-C00025.png)
BE2014C027I2 (US07179617-20070220-C00025.png)
BE2014C003I2 (US07179617-20070220-C00025.png)
BE2013C075I2 (US07179617-20070220-C00025.png)
BE2013C070I2 (US07179617-20070220-C00025.png)
BE2013C067I2 (US07179617-20070220-C00025.png)
BE2013C038I2 (US07179617-20070220-C00025.png)
BE2013C036I2 (US07179617-20070220-C00025.png)
BE2011C030I2 (US07179617-20070220-C00025.png)
JP2004167250A5 (US07179617-20070220-C00025.png)
JP2004145273A5 (US07179617-20070220-C00025.png)
JP2003288143A5 (US07179617-20070220-C00025.png)
JP2004094924A5 (US07179617-20070220-C00025.png)
BE2015C005I2 (US07179617-20070220-C00025.png)
JP2004088083A5 (US07179617-20070220-C00025.png)
BE2012C053I2 (US07179617-20070220-C00025.png)
JP2004140789A5 (US07179617-20070220-C00025.png)
JP2003314221A5 (US07179617-20070220-C00025.png)
JP2004029020A5 (US07179617-20070220-C00025.png)
JP2004080762A5 (US07179617-20070220-C00025.png)
JP2004007610A5 (US07179617-20070220-C00025.png)
JP2004031327A5 (US07179617-20070220-C00025.png)
DK200200343U3 (US07179617-20070220-C00025.png)
JP2004209165A5 (US07179617-20070220-C00025.png)